D
Verrica Pharmaceuticals Inc. VRCA
$5.16 -$0.07-1.34% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 102.09% 39.87% 29.13% -33.02% 15.47%
Total Depreciation and Amortization -4.33% -17.79% -26.02% 2.40% -1.76%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -19.61% -63.71% 35.24% 1.91% 12.92%
Change in Net Operating Assets -153.10% -12.10% -137.12% 560.90% 4.78%
Cash from Operations 20.77% 21.08% -87.71% 47.68% 17.99%
Capital Expenditure -- -- 100.00% -45.45% --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- 150.00% -45.45% --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -2.42% -984.76% -72.35% -22.60% -13.46%
Issuance of Common Stock -- -- -- -100.00% 3,650.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 190.00% 70.64% -20.43%
Cash from Financing -2.42% -110.29% 10,030.98% 37.97% 3.18%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 15.15% -171.60% 360.51% 47.26% 17.46%